Related Experiment Video
Updated: Jul 30, 2026
11:56
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Antibacterial drug discovery: is small pharma the solution?
1Biotechnology and Pharmaceutical Consulting, Menlo Park, CA.
Summary
Small pharmaceutical companies are driving antibacterial research, often by reviving abandoned drug programs. This shift addresses the decline in antibacterial discovery within larger corporations, highlighting a new era for antibiotic development.
Area of Science:
- Pharmaceutical Science
- Infectious Diseases
- Drug Discovery
Background:
- Antibacterial research has seen a decline in major pharmaceutical companies.
- Small pharmaceutical companies are increasingly active in antibacterial discovery.
- At least 35 small companies are currently engaged in antibacterial research.
Purpose of the Study:
- To outline the current landscape of antibacterial research conducted by small pharmaceutical companies.
- To discuss strategies employed by small companies, such as continuing abandoned clinical programs.
- To identify and propose changes to address challenges in this field.
Main Methods:
- Review of current activities in small pharmaceutical companies focused on antibacterial discovery.
- Analysis of strategies, including the continuation of previously discontinued clinical programs.
- Identification of issues and proposal of changes related to small company-led antibacterial research.
Main Results:
- Small companies are actively filling the gap left by larger pharmaceutical firms in antibacterial research.
- A significant number of small companies (at least 35) are involved in this field.
- Resuming abandoned clinical programs is a successful strategy for small pharma.
Conclusions:
- Small pharmaceutical companies are crucial for the future of antibacterial drug discovery.
- Strategic continuation of abandoned programs offers a viable path forward.
- Addressing specific issues is necessary to further support small company initiatives in combating bacterial infections.
Related Concept Videos
00:57Antibiotic Selection
Overview
01:30Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:28Biological Methods for Microbial Control
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
01:28Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...